Loading

Best Practices for Managing Your Biotech’s Ca$hflow

June 04, 2024
Breakout Session
Business Development and Investment
32AB
Even companies flush with cash need to be savvy as to financial options when facing a down-market and onerous financing alternatives. Is your Board armed with an understanding of the ins and outs of financial survival? This panel will cover various alternatives, including collaborations, selling assets, reverse mergers, filing a Chapter XI bankruptcy case, and dissolving - presenting the advantages and disadvantages of each alternative.
Speakers
Joel Papernik, JD
Member
Mintz
Speakers
Robert Easton
Eastern Strategy, LLC
Heidi Henson
Director
Lisata Therapeutics
Barbara Wood
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS